| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |